businesspress24.com - Biotech: Pressemitteilungen - Kategorie - Seite 57
 
PresseMitteilungen

Biotech

Category / Pharmaceuticals & Biotech / Biotech

J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors

MINNEAPOLIS, MN: Two Experienced Healthcare Executives Join Board as Company Prepares to Enroll First Patient in Phase 1 Clinical Trial ...

Medivation Announces Management Changes

SAN FRANCISCO, CA: Medivation Announces Appointment of Mohammad Hirmand, M.D., as Interim CMO; Lynn Seely, M.D., Retiring From CMO Position; New Hires Complement Current Leadership Expertise ...

Updated Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 European Cancer Congress

SAN FRANCISCO, CA: Updated Exploratory Analysis of Survival Indicates TNBC Patients in the Study Who Tested Positive for a Novel Gene Expression Profiling Assay Have to Date Experienced a 10.5-Month Longer Median Surviv ...

Corbus Pharmaceuticals to Present Additional Data on the Effects of Resunab(TM) in the Treatment of Pulmonary Infection and Inflammation in Pre-Clinical Models of Cystic Fibrosis

NORWOOD, MA: Data to Be Presented at the North American Cystic Fibrosis Conference October 8-10, 2015; Resunab Demonstrated Improvement in Lung Inflammation and Infection in Cystic Fibrosis Pre-Clinical Model ...

Data From New Studies Confirm In Vitro Potency of VIBATIV(R) (Telavancin) Against Gram-Positive Bacteria, Including MRSA

DUBLIN, IRELAND: In Vitro Potency Results Presented at 2015 ICAAC Demonstrate Advantage for VIBATIV Against Difficult-to-Treat Infections as Compared to Vancomycin, Daptomycin and Linezolid ...

Atossa Genetics Announces FDA Acceptance of Its Investigational New Drug Application to Begin a Phase II Clinical Trial of Fulvestrant for the Treatment of DCIS

SEATTLE, WA: Study to Evaluate Fulvestrant Administered With Atossa's Patented Intraductal Microcatheters; Atossa Now Has Two Phase II Clinical Programs ...

Corbus Pharmaceuticals Commences Patient Enrollment in Phase 2 Clinical Study of Resunab(TM) for the Treatment of Cystic Fibrosis

NORWOOD, MA: Study in Cystic Fibrosis Is the Third Phase 2 Clinical Trial Underway With Resunab for Treatment of Rare, Serious Inflammatory and Fibrotic Diseases ...


Page 57 von 247:  1 « ..  56 57 58  59  60  61  62  63  64  65  .. » 247





 

Who is online

All members: 10 564
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 70


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.